Increased reactive oxygen species (ROS) promote matrix metalloproteinase (MMP) activities and may underlie cardiomyocyte injury and the degradation of cardiac troponin I (cTI) during acute pulmonary thromboembolism (APT). We examined whether pretreatment or therapy with tempol (a ROS scavenger) prevents MMP activation and cardiomyocyte injury of APT. Anesthetized sheep received tempol infusion (1.0 mg kg(-1) min(-1), i.v.) or saline starting 30 min before or 30 min after APT (autologous blood clots). Control animals received saline. Hemodynamic measurements were performed. MMPs were studied in the right ventricle (RV) by gelatin zymography, fluorimetric activity assay, and in situ zymography. The ROS levels were determined in the RV and cTI...
AbstractObjectives: We tested whether nitric oxide scavenging with a ruthenium-based compound (AMD62...
The authors examined whether acute pulmonary embolism (APE) increases lung matrix metalloproteinase ...
Introduction: Fibrinolyis is one of the first line therapies in high risk pulmonary embolism (PE) ac...
Increased reactive oxygen species (ROS) promote matrix metalloproteinase (MMP) activities and may un...
Objectives: Up-regulated matrix metalloproteinases may be involved in the development of cardiomyocy...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Background: Making the diagnosis of acute pulmonary thromboembolism (APT) and assessing its severity...
O diagnóstico da tromboembolia pulmonar aguda (EPA) e a avaliação da gravidade desta condição é desa...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Introduction: Inhibition of matrix metalloproteinases (MMPs) improves the hemodynamics during acute ...
AbstractWe investigated whether atorvastatin has beneficial hemodynamic effects during acute pulmona...
Matrix metalloproteinases (MMPs), activated by oxidative stress, play a key role during cardiac remo...
Matrix metalloproteinase (MMP) activation contributes to the development of various pathophysiologic...
The authors examined whether acute pulmonary embolism (APE) increases lung matrix metal-loproteinase...
Increased mitochondrial reactive oxygen species (ROS), particularly superoxide have been suggested t...
AbstractObjectives: We tested whether nitric oxide scavenging with a ruthenium-based compound (AMD62...
The authors examined whether acute pulmonary embolism (APE) increases lung matrix metalloproteinase ...
Introduction: Fibrinolyis is one of the first line therapies in high risk pulmonary embolism (PE) ac...
Increased reactive oxygen species (ROS) promote matrix metalloproteinase (MMP) activities and may un...
Objectives: Up-regulated matrix metalloproteinases may be involved in the development of cardiomyocy...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Background: Making the diagnosis of acute pulmonary thromboembolism (APT) and assessing its severity...
O diagnóstico da tromboembolia pulmonar aguda (EPA) e a avaliação da gravidade desta condição é desa...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Ci...
Introduction: Inhibition of matrix metalloproteinases (MMPs) improves the hemodynamics during acute ...
AbstractWe investigated whether atorvastatin has beneficial hemodynamic effects during acute pulmona...
Matrix metalloproteinases (MMPs), activated by oxidative stress, play a key role during cardiac remo...
Matrix metalloproteinase (MMP) activation contributes to the development of various pathophysiologic...
The authors examined whether acute pulmonary embolism (APE) increases lung matrix metal-loproteinase...
Increased mitochondrial reactive oxygen species (ROS), particularly superoxide have been suggested t...
AbstractObjectives: We tested whether nitric oxide scavenging with a ruthenium-based compound (AMD62...
The authors examined whether acute pulmonary embolism (APE) increases lung matrix metalloproteinase ...
Introduction: Fibrinolyis is one of the first line therapies in high risk pulmonary embolism (PE) ac...